Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

Slides:

Advertisements

Similar presentations

Laboratory diagnosis and biosafety issues of biological warfare agents

Advertisements

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Grepafloxacin: microbiological properties

Approach to diagnosis of infective endocarditis

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children R.-P. Janapatla, M.-H.

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

E. Lindberg, I. Adlerberth, A.E. Wold

Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre.

Didier Guillemot, Claude Carbon Clinical Microbiology and Infection

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

Structure of grepafloxacin relative to activity and safety profile

D.E. Low Clinical Microbiology and Infection

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage Ron Dagan, Drora Fraser, Noga Givon, Pablo.

Training for the infectious diseases speciality in Norway

The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model Matthew O'Brien, Thuy Quach,

Cephalosporins: a pharmacological update

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro

Antibiotic usage and the incidence of resistance

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Charlotte Larsson, Reba Kanungo, Gunnar Kahlmeter, R

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Anders Österlund, Lars Engstrand Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe Anna King, Julie Downes, Carl-Erik Nord, Ian.

G.R. Davies Clinical Microbiology and Infection

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.

Community-acquired pneumonia: epidemiologic and clinical consideration

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Definition of the Clinical Antibacterial Spectrum of Activity

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model Alasdair P. MacGowan,

Sanford Chodosh Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release J. SjöUlin,

New oral cephalosporins in pediatric community-acquired infections

Moving from recommendation to implementation and audit: Part 1

M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür

Modification of prescribers’ behavior: the Icelandic approach

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Impact of antibiotic restrictions: the patient's perspective

Fernando Baquero, John F

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology and Infection Volume 5, Pages 4S48-4S54 (August 1999) DOI: 10.1111/j.1469-0691.1999.tb00857.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Percentage of pneumococcal isolates with reduced susceptibility to penicillin (MIC ≤0.12 mg/L) in Malmöhus County, southern Sweden, and all Sweden in 1994–97. The data derive from a survey of the resistance of approximately 3000 strains of Streptococcus pyogenes, Haemophilus influenzae and S. pneumoniae to a number of commonly used antibiotics, performed each year by The Swedish Reference Group for Antibiotics (SRGA) [8]. Clinical Microbiology and Infection 1999 5, 4S48-4S54DOI: (10.1111/j.1469-0691.1999.tb00857.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Monthly number of PRP cases in Malmöhus County, shown as index cases and contact cases. Clinical Microbiology and Infection 1999 5, 4S48-4S54DOI: (10.1111/j.1469-0691.1999.tb00857.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Map of Malmöhus County with the most likely routes of clonal spread of PRP serotype 9V. The table gives the month when the clone was first identified in a community. In the three communities Hörby, Sjöbo and Ystad, this clone has not yet been identified. Clinical Microbiology and Infection 1999 5, 4S48-4S54DOI: (10.1111/j.1469-0691.1999.tb00857.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Antibiotic sales statistics for selected oral antibiotics expressed in defined daily doses (DDD) per 1000 inhabitants in Sweden [24,25]. TMP/SMX, trimethoprim–sulfamethoxozole. Clinical Microbiology and Infection 1999 5, 4S48-4S54DOI: (10.1111/j.1469-0691.1999.tb00857.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions